Foghorn Therapeutics
FHTX
#8327
Rank
ยฃ0.13 B
Marketcap
ยฃ2.43
Share price
-7.02%
Change (1 day)
-56.36%
Change (1 year)

Revenue for Foghorn Therapeutics (FHTX)

Revenue in 2024 (TTM): ยฃ17.55 Million

According to Foghorn Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ17.26 Million. a decrease over the revenue in the year 2023 that were of ยฃ26.8 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Foghorn Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ18.01 M-32.82%
2023 ยฃ26.8 M68.68%
2022 ยฃ15.89 M1526.51%
2021 ยฃ0.97 M209.75%
2020 ยฃ0.31 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA